Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
about
Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesNeuroimmunology of Huntington's Disease: Revisiting Evidence from Human StudiesPlasma epidermal growth factor decreased in the early stage of Parkinson's disease.Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases.Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individualsRecent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.Cognitive decline in Parkinson disease.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment.TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF.Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia.Association Between Peripheral Inflammation and DATSCAN Data of the Striatal Nuclei in Different Motor Subtypes of Parkinson Disease.Effects of Bushen-Yizhi formula on age-related inflammation and oxidative stress in senescence-accelerated mice.
P2860
Q26795984-65C76457-9B49-4E53-BA76-732A101A6B6CQ28072237-CA2E82B3-C40D-4B08-93E5-BFBACEF771A8Q35636853-0CF312F2-DC70-4420-B952-747AB35398C9Q36460964-FCD390C2-8A0E-45EA-A0F2-6500365C0F45Q36618909-6F9C5961-EECD-4E63-B058-46851B3A7A7AQ38315590-A432942A-85FB-45B5-A978-4F3D4012E94AQ38613326-06EAAB7D-D483-4C7F-B5E8-61AB8A60DC1EQ38751099-3038BA2A-B0F0-4508-9DEB-6F8F2A9C5732Q39010887-D836A612-5CA8-41B2-B3B4-B0F425A834D1Q42001519-D7BEF5ED-73ED-4DFE-85A3-71452324EA36Q46279808-141771B9-2358-4525-BB98-02A4318C949DQ47435866-B35C2324-B9CA-430B-B87A-922AE2FCD4FFQ48137846-CE640D58-2C71-4D74-A2AE-5BF878893AC1Q48590246-996D138D-3400-4ECC-A012-57530EC9A534Q50419806-F0D345D7-2AE5-4CC5-9B25-4B5B9E6C1209Q55228224-CC58FE24-0F44-4F63-93F8-63F456656E6EQ55399744-756F8919-6CC7-4E36-AD70-7F568CDBE23A
P2860
Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@en
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@nl
type
label
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@en
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@nl
prefLabel
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@en
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Plasma levels of soluble tumor ...... rmance in Parkinson's disease.
@en
P2093
András Palotás
Helton José Reis
Isabela Boechat Morato
Izabela Guimarães Barbosa
Mariana Soares de Sousa
Paula Luciana Scalzo
Paulo Pereira Christo
P2860
P304
P356
10.1002/MDS.25752
P407
P577
2013-12-03T00:00:00Z